And you don't reject $4m offer if you think you are sure to lose.
who knows maybe Peregrine ironically benefits from CSM refusing to settle for $4M and maybe CSM knows they truly did comment sabotage and would be likely forced to pay much higher amounts
maybe after early May they surprisingly all decide to settle and it works well for all sides
new stock option awards closing in soon and a nice milestone would be Phase III trial enrollment numbers to support the biggest stock options awarded ever at Peregrine and no one will be complaining, because for those with stock options to be rewarded the pps must go up
The pps will go up
Soon and oh so soon
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!